← Leaderboards
M. Begona Delgado-Charro
University Of Maryland Baltimore
$1,244,960
Attributed
$3,082,455
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $500K · FY2013–25$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
FDA$3,082,455 · 2
By mechanism
U01$3,082,455 · 2
Top collaborators
- Annette L Bunge5 shared
- Richard H Guy5 shared
- Audra L Stinchcomb5 shared
- Stephen W. Hoag3 shared
Grant awards (8)
Development and Validation of a Multi-functional, Multi-purpose Quantitative Tool for Dermal Physiologically-Based Pharmacokinetic Modeling$246,357
U01 · FY2025 · FD · contact PI
Development and Validation of a Multi-functional, Multi-purpose Quantitative Tool for Dermal Physiologically-Based Pharmacokinetic Modeling$243,950
U01 · FY2024 · FD · contact PI
Development and Validation of a Multi-functional, Multi-purpose Quantitative Tool for Dermal Physiologically-Based Pharmacokinetic Modeling$242,154
U01 · FY2023 · FD · contact PI
Bioequivalence of topical drug products: in vitro - in vivo correlations$499,999
U01 · FY2017 · FD
Bioequivalence of topical drug products: in vitro - in vivo correlations$350,000
U01 · FY2016 · FD
Bioequivalence of topical drug products: in vitro - in vivo correlations$499,999
U01 · FY2015 · FD
Bioequivalence of topical drug products: in vitro - in vivo correlations$499,998
U01 · FY2014 · FD
Bioequivalence of topical drug products: in vitro - in vivo correlations$499,998
U01 · FY2013 · FD